Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) is a weak GSK-3β inhibitor, IC50﹥ 100μM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
5 mg | In stock | $ 447.00 | |
10 mg | In stock | $ 659.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,380.00 | |
100 mg | In stock | $ 1,890.00 | |
500 mg | In stock | $ 3,790.00 |
Description | GSK-3β inhibitor 14 (1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)-) is a weak GSK-3β inhibitor, IC50﹥ 100μM. |
Targets&IC50 | GSK-3β:﹥ 100μM |
Synonyms | 1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)- |
Molecular Weight | 283.39 |
Formula | C17H17NOS |
CAS No. | 863004-48-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 2.7 mg/mL (9.5 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK-3β inhibitor 14 863004-48-2 PI3K/Akt/mTOR signaling Stem Cells GSK-3 GSK-3beta inhibitor 14 GSK-3b inhibitor 14 1,5-Benzothiazepin-4(5H)-one, 2,3-dihydro-2-methyl-5-(phenylmethyl)- inhibitor inhibit